Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mixed Data on Amgen's Vectibix
Yahoo/Zacks.com
Thursday, September 24, 2009 - 3:33pm
tags:
Amgen, Vectibix, Folfiri, cancer
Jazz and Transcept Pharmaceuticals on the Rise
Seeking Alpha
Thursday, September 24, 2009 - 11:23am
tags:
Jazz Pharmaceuticals, Transcept
In a stunner, Chelsea's hypotension drug flunks Phase III
Fierce Biotech
Thursday, September 24, 2009 - 11:20am
tags:
Chelsea Therapeutics, hypertension, drug trials, Droxidopa
Merck Gives $500 Million of Vaccine to Poorer Nations
Bloomberg
Thursday, September 24, 2009 - 11:17am
tags:
Merck, vaccines, donations, Gardasil
Bristol-Myers still hungry for deals after Medarex
Reuters
Thursday, September 24, 2009 - 11:15am
tags:
Bristol-Myers Squibb, Medarex, M&A
Abbott, UCB touted as bidders for Solvay's pharma division
Pharma Times, UK
Thursday, September 24, 2009 - 11:14am
tags:
Abbott Laboratories, UCB Pharmaceuticals, M&A, Solvay
Dendreon Investor Meeting: CFO Gives Provenge Sales Guidance
TheStreet.com
Thursday, September 24, 2009 - 11:05am
tags:
Dendreon, Provenge, prostate cancer
Playing Devil's Advocate on the Talecris IPO: A Banker Provides the Contrarian View
BNET Pharma
Thursday, September 24, 2009 - 11:04am
tags:
IPOs, Talecris
Cephalon gets priority review for jet-lag drug
Marketwatch
Thursday, September 24, 2009 - 11:02am
tags:
jet lag, Cephalon, NUVIGIL
AIDS Vaccine Found To Cut Risk of Getting HIV
TheStreet.com
Thursday, September 24, 2009 - 11:01am
tags:
AIDS, vaccines, HIV, Sanofi, VaxGen
Device Makers May Win Cut in Tax for Health Revamp
Bloomberg
Thursday, September 24, 2009 - 10:39am
tags:
healthcare reform, medical devices
Spectrum Pharmaceuticals: Undervalued and (Now) Oversold
Seeking Alpha
Thursday, September 24, 2009 - 10:38am
tags:
Spectrum Pharmaceuticals
Merck to publish GP payments
FT.com
Thursday, September 24, 2009 - 10:37am
tags:
Merck, physician payments
Eli Lilly Wins Ruling on Evista Patent Validity
Bloomberg
Wednesday, September 23, 2009 - 9:04pm
tags:
Evista, patents, Teva Pharmaceuticals, Eli Lilly
Alkermes Needs Some Financial Alchemy
Motley Fool
Wednesday, September 23, 2009 - 9:02pm
tags:
Alkermes, Eli Lilly, JNJ, Cephalon, exanitide
Merck, Wyeth execs see Big Pharma survival edge
Reuters
Wednesday, September 23, 2009 - 3:59pm
tags:
Merck, Wyeth, Big Pharma
[video] Bio-tech High Times
TheStreet.com
Wednesday, September 23, 2009 - 3:55pm
tags:
biotech
Testing Time for Allos
Yahoo/Zacks.com
Wednesday, September 23, 2009 - 3:54pm
tags:
Allos
PhRMA deal draws Senate fire
Fierce Pharma
Wednesday, September 23, 2009 - 2:25pm
tags:
PhRMA, Senate, healthcare reform
Abbott touts safety of Xience stent in diabetics, eyes Boston Scientific market share
Yahoo/AP
Wednesday, September 23, 2009 - 2:23pm
tags:
Abbott Laboratories, Xience, stents, diabetes, Boston Scientific

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.